2012
DOI: 10.21767/amj.2012.1127
|View full text |Cite
|
Sign up to set email alerts
|

EDITORIAL WHAT ROLE FOR PROTEIN‐CONJUGATE PNEUMOCOCCAL VACCINE IN OLDER ADULTS? Invasive pneumococcal disease is a significant cause of morbidity and mortality among persons aged 65 years and older. Pneumococcal disease burden also remains high among adults over 50 years of age. In this editorial the authors discuss the priority of continued 23‐valent pneumococcal polysaccharide vaccine use in older adults, whilst also emphasising the importance of directing future attention to the development of vacci

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 0 publications
0
0
0
Order By: Relevance